Format

Send to

Choose Destination
See comment in PubMed Commons below
Ann Hepatol. 2014 Mar-Apr;13(2):204-10.

Factors affecting screening for hepatocellular carcinoma.

Author information

  • 1Hepatology, Department of Clinical Research, University of Bern. Switzerland.
  • 2University Clinic for Visceral Surgery and Medicine, Inselspital, University of Bern. Switzerland.
  • 3Institut of Social and Preventive Medicine, University of Bern. Switzerland.
  • 4Department of Oncology, Inselspital, University of Bern. Switzerland.
  • 5Department of Radiology, Inselspital, University of Bern. Switzerland.
  • 6Hepatology, Department of Clinical Research, University of Bern. Switzerland; University Clinic for Visceral Surgery and Medicine, Inselspital, University of Bern. Switzerland.

Abstract

BACKGROUND AND AIM:

Hepatocellular carcinoma (HCC) is a frequent cancer. Its prognosis is highly dependent on early diagnosis. Patients at risk for developing HCC should be enrolled in a surveillance programme. Nevertheless, many patients at risk are not regularly screened. We aimed at exploring the characteristics that affect enrolment in a surveillance programme.

MATERIAL AND METHODS:

The characteristics of the patients included in the prospective Bern HCC cohort between August 2010 and August 2011 were analysed according to their participation in a surveillance programme.

RESULTS:

Among the 82 patients included in the cohort during this period of time, 48 were in a surveillance program before the diagnosis of HCC. Thirty five percent of cirrhotic patients were not screened. Age, sex, level of education, Child-Pugh status and MELD score were similar between the patients who were screened and those who were not screened. Patients with a private insurance and patients treated by a liver specialist were more frequently enrolled in a surveillance program. Sixty seven percent of the screened patients were eligible for curative treatment whereas only 15% of the non-screened patients were.

CONCLUSIONS:

In conclusion the surveillance of patients at risk for developing HCC increases their chances to be diagnosed at an early stage to allow curative treatment. More than one third of cirrhotic patients were not regularly screened. Patients with chronic liver disease should be referred to identify those at risk and enrol them in a surveillance program.

PMID:
24552862
[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for IndexCopernicus
    Loading ...
    Write to the Help Desk